Connection

Jinghua Yan to Viral Vaccines

Back to Details
This is a "connection" page, showing publications Jinghua Yan has written about Viral Vaccines.
Jinghua Yan
Connection Strength
0.256
Viral Vaccines
  1. Particulate Alum via Pickering Emulsion for an Enhanced COVID-19 Vaccine Adjuvant. Adv Mater. 2020 Oct; 32(40):e2004210.
    View in: PubMed
    Score: 0.047
  2. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates. Vaccine. 2019 04 03; 37(15):2122-2130.
    View in: PubMed
    Score: 0.042
  3. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage. J Virol. 2018 03 15; 92(6).
    View in: PubMed
    Score: 0.039
  4. Monoclonal Antibodies against Zika Virus: Therapeutics and Their Implications for Vaccine Design. J Virol. 2017 10 15; 91(20).
    View in: PubMed
    Score: 0.038
  5. Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice. Antiviral Res. 2017 04; 140:55-61.
    View in: PubMed
    Score: 0.036
  6. MERS-CoV spike protein: Targets for vaccines and therapeutics. Antiviral Res. 2016 09; 133:165-77.
    View in: PubMed
    Score: 0.035
  7. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Cell. 2020 08 06; 182(3):722-733.e11.
    View in: PubMed
    Score: 0.012
  8. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J Infect Dis. 2010 Oct 15; 202(8):1171-80.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.